Fundraising Fox
PetVivo Holdings
OTC: PETVEdina, US · Nevada corporation
Find your way into PetVivo Holdings
Sign up to see every warm intro you have to PetVivo Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PetVivo Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PetVivo is a veterinary biotech and biomedical device company that adapts human biotech and medical technology into products for the veterinary market. Its lead product, Spryng with OsteoCushion Technology, uses proprietary protein-based biomaterials to manage joint pain, lameness, and osteoarthritis in companion animals such as dogs and horses.
Founders & leadership
RJ
Robert J. FolkesChief Financial Officer2021–2024Robert J. Folkes is Chief Financial Officer at PetVivo Holdings, a veterinary biotech company. He brings over 25 years of financial executive experience in high-growth public companies and private equity-backed businesses, with expertise in financial and operational strategy for scaling organizations.
RM
Randall MeyerChief Operating Officer
DD
David D. DemingNamed on SEC filing
WC
Wesley C. HayneNamed on SEC filing
JF
John F. DolanNamed on SEC filing
DB
David B. MastersNamed on SEC filing
PV
Peter VezmarNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$391K disclosed across 1 round · 2017
▶$391KraisedSep 2017 · 30 investors · BiotechnologyRule 506(b)
▶$391KraisedSep 2017 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David D. DemingDirector
- Wesley C. HayneExecutive Officer, Director
- John LaiExecutive Officer, Director
- Randall A. MeyerExecutive Officer, Director
- John F. DolanExecutive Officer, Director
- David B. MastersExecutive Officer, Director
- Peter VezmarDirector
- Offering amount
- $525K
- Amount sold
- $391K
- Minimum investment
- $5K
- Proceeds to insiders
- $50K
- First sale
- Jul 2017
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$43.2Mvaluation at IPOAug 2021 · $4.50/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Related companies · 5
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Dvm360dvm360 is a veterinary medicine news and education publisher, delivering clinical articles, video shorts, continuing education, and conference coverage for veterinarians, technicians, and practice staff. It also produces a digital edition and reports on industry developments across the veterinary profession.
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
VcahospitalsVCA Animal Hospitals operates a national network of veterinary hospitals providing primary care, specialty care, emergency care, urgent care, and boarding services for pets. The company combines advanced medical technology and procedures with compassionate care for pet owners and their animals.
InVivo BiosystemsBiotechnology company providing solutions for genetic research and drug discovery.
Companies working in the same space as PetVivo Holdings.
In the news
Frequently asked questions
- What does PetVivo Holdings do?
- PetVivo is a veterinary biotech and biomedical device company that adapts human biotech and medical technology into products for the veterinary market. Its lead product, Spryng with OsteoCushion Technology, uses proprietary protein-based biomaterials to manage joint pain, lameness, and osteoarthritis in companion animals such as dogs and horses.
- How much funding has PetVivo Holdings raised?
- PetVivo Holdings has disclosed $391K raised across 1 round.
- Where is PetVivo Holdings headquartered?
- PetVivo Holdings is headquartered in Edina, US.